|
|
Volumn 32, Issue 14, 2014, Pages 1412-1418
|
|
Randomized, controlled, double-blind, cross-over trial assessing treatment preference for pazopanib versus sunitinib in patients with metastatic renal cell carcinoma: PISCES study
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
PAZOPANIB;
SUNITINIB;
ANTINEOPLASTIC AGENT;
INDOLE DERIVATIVE;
PYRIMIDINE DERIVATIVE;
PYRROLE DERIVATIVE;
SULFONAMIDE;
ABDOMINAL PAIN;
ADULT;
ARTICLE;
ASTHENIA;
CANCER FATIGUE;
CANCER THERAPY;
CLINICAL EVALUATION;
CONSTIPATION;
CONTROLLED STUDY;
CROSSOVER PROCEDURE;
DECREASED APPETITE;
DIARRHEA;
DISEASE COURSE;
DOUBLE BLIND PROCEDURE;
DRUG DOSE REDUCTION;
DRUG ERUPTION;
DRUG EXPOSURE;
DRUG INDUCED HEADACHE;
DRUG SAFETY;
DRUG WITHDRAWAL;
DYSGEUSIA;
DYSPEPSIA;
DYSPNEA;
EPISTAXIS;
FEMALE;
HAND FOOT SYNDROME;
HEALTH CARE PERSONNEL;
HUMAN;
HYPERTENSION;
INTENTION TO TREAT ANALYSIS;
KIDNEY METASTASIS;
MAJOR CLINICAL STUDY;
MALE;
MOUTH INFLAMMATION;
MULTICENTER STUDY;
NAUSEA;
OUTCOME ASSESSMENT;
PATIENT PREFERENCE;
PERITONITIS;
PHASE 3 CLINICAL TRIAL;
PRIORITY JOURNAL;
QUALITY OF LIFE;
QUESTIONNAIRE;
RANDOMIZED CONTROLLED TRIAL;
RESPIRATORY FAILURE;
SENSITIVITY ANALYSIS;
STOMATITIS;
VOMITING;
AGED;
CONTROLLED CLINICAL TRIAL;
KIDNEY CARCINOMA;
KIDNEY TUMOR;
METASTASIS;
MIDDLE AGED;
PATHOLOGY;
PHASE 2 CLINICAL TRIAL;
AGED;
ANTINEOPLASTIC AGENTS;
CARCINOMA, RENAL CELL;
CROSS-OVER STUDIES;
DOUBLE-BLIND METHOD;
FEMALE;
HUMANS;
INDOLES;
KIDNEY NEOPLASMS;
MALE;
MIDDLE AGED;
PATIENT PREFERENCE;
PYRIMIDINES;
PYRROLES;
QUALITY OF LIFE;
QUESTIONNAIRES;
SULFONAMIDES;
|
|
EID: 84902986833
PISSN: 0732183X
EISSN: 15277755
Source Type: Journal
DOI: 10.1200/JCO.2013.50.8267 Document Type: Article |
|
Times cited : (348)
|
|
References (12)
|
